These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27738605)

  • 21. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation.
    Angelberger S; Reinisch W; Makristathis A; Lichtenberger C; Dejaco C; Papay P; Novacek G; Trauner M; Loy A; Berry D
    Am J Gastroenterol; 2013 Oct; 108(10):1620-30. PubMed ID: 24060759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of fecal microbiota transplantation
    Tkach S; Dorofeyev A; Kuzenko I; Falalyeyeva T; Tsyryuk O; Kovalchuk O; Kobyliak N; Abenavoli L; Boccuto L
    Front Med (Lausanne); 2022; 9():1049849. PubMed ID: 36714101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics.
    Ishikawa D; Sasaki T; Takahashi M; Kuwahara-Arai K; Haga K; Ito S; Okahara K; Nakajima A; Shibuya T; Osada T; Hiramatsu K; Watanabe S; Nagahara A
    Inflamm Bowel Dis; 2018 Nov; 24(12):2590-2598. PubMed ID: 30124831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated - an open-label pilot study.
    Cold F; Browne PD; Günther S; Halkjaer SI; Petersen AM; Al-Gibouri Z; Hansen LH; Christensen AH
    Scand J Gastroenterol; 2019 Mar; 54(3):289-296. PubMed ID: 30946615
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.
    Nishida A; Imaeda H; Ohno M; Inatomi O; Bamba S; Sugimoto M; Andoh A
    J Gastroenterol; 2017 Apr; 52(4):476-482. PubMed ID: 27730312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
    Goyal A; Yeh A; Bush BR; Firek BA; Siebold LM; Rogers MB; Kufen AD; Morowitz MJ
    Inflamm Bowel Dis; 2018 Jan; 24(2):410-421. PubMed ID: 29361092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.
    Ishikawa D; Sasaki T; Osada T; Kuwahara-Arai K; Haga K; Shibuya T; Hiramatsu K; Watanabe S
    Inflamm Bowel Dis; 2017 Jan; 23(1):116-125. PubMed ID: 27893543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis.
    Ponce-Alonso M; García-Hoz C; Halperin A; Nuño J; Nicolás P; Martínez-Pérez A; Ocaña J; García-Pérez JC; Guerrero A; López-Sanromán A; Cantón R; Roy G; Del Campo R
    Front Immunol; 2021; 12():683387. PubMed ID: 34149723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora.
    Wei Y; Gong J; Zhu W; Tian H; Ding C; Gu L; Li N; Li J
    BMC Microbiol; 2016 Nov; 16(1):255. PubMed ID: 27809778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation.
    Marshall DA; MacDonald KV; Kao D; Bernstein CN; Kaplan GG; Jijon H; Hazlewood G; Panaccione R; Nasser Y; Raman M; Moayyedi P
    Ther Adv Chronic Dis; 2024; 15():20406223241239168. PubMed ID: 38544906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal microbiota transplantation ameliorates active ulcerative colitis.
    Chen HT; Huang HL; Xu HM; Luo QL; He J; Li YQ; Zhou YL; Nie YQ; Zhou YJ
    Exp Ther Med; 2020 Apr; 19(4):2650-2660. PubMed ID: 32256746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal transplantation for ulcerative colitis: current evidence and future applications.
    Lopetuso LR; Ianiro G; Allegretti JR; Bibbò S; Gasbarrini A; Scaldaferri F; Cammarota G
    Expert Opin Biol Ther; 2020 Apr; 20(4):343-351. PubMed ID: 32083498
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of Different Treatment of Fecal Microbiota Transplantation Techniques on Treatment of Ulcerative Colitis in Rats.
    Zhu F; Ke Y; Luo Y; Wu J; Wu P; Ma F; Liu Y
    Front Microbiol; 2021; 12():683234. PubMed ID: 34335508
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis.
    Kunde S; Pham A; Bonczyk S; Crumb T; Duba M; Conrad H; Cloney D; Kugathasan S
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):597-601. PubMed ID: 23542823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Two-Week Fecal Microbiota Transplantation Course in Pediatric Patients with Inflammatory Bowel Disease.
    Karolewska-Bochenek K; Grzesiowski P; Banaszkiewicz A; Gawronska A; Kotowska M; Dziekiewicz M; Albrecht P; Radzikowski A; Lazowska-Przeorek I
    Adv Exp Med Biol; 2018; 1047():81-87. PubMed ID: 29151253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific fungi associated with response to capsulized fecal microbiota transplantation in patients with active ulcerative colitis.
    Chen Q; Fan Y; Zhang B; Yan C; Chen Z; Wang L; Hu Y; Huang Q; Su J; Ren J; Xu H
    Front Cell Infect Microbiol; 2022; 12():1086885. PubMed ID: 36683707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation.
    Xu HM; Huang HL; Xu J; He J; Zhao C; Peng Y; Zhao HL; Huang WQ; Cao CY; Zhou YJ; Zhou YL; Nie YQ
    Front Microbiol; 2021; 12():658292. PubMed ID: 33912150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal Microbiome Changes and Clinical Outcomes of Patients with Ulcerative Colitis after Fecal Microbiota Transplantation.
    Tikunov AY; Fedorets VA; Shrainer EV; Morozov VV; Bystrova VI; Tikunova NV
    J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceptability, tolerability, and safety of fecal microbiota transplantation in patients with active ulcerative colitis (AT&S Study).
    Sood A; Singh A; Mahajan R; Midha V; Mehta V; Gupta YK; Narang V; Kaur K
    J Gastroenterol Hepatol; 2020 Mar; 35(3):418-424. PubMed ID: 31408913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal microbiota transplantation for recurrent
    Nanki K; Mizuno S; Matsuoka K; Ono K; Sugimoto S; Kiyohara H; Arai M; Nakashima M; Takeshita K; Saigusa K; Senoh M; Fukuda T; Naganuma M; Kato H; Suda W; Hattori M; Kanai T
    Intest Res; 2018 Jan; 16(1):142-146. PubMed ID: 29422809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.